Indian Journal of Urology Users online:14313  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Low-dose versus standard-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials
Se Young Choi,Moon Soo Ha,Jung Hoon Kim,Byung Hoon Chi,Jin Wook Kim,In Ho Chang,Tae-Hyoung Kim,Soon Chul Myung
Investigative and Clinical Urology.2022;63(2)140
2The Safety and Efficacy of Different Doses of Bacillus Calmette Guérin in Superficial Bladder Transitional Cell Carcinoma
Madhu S. Agrawal,Moneet Agrawal,Sumit Bansal,Mayank Agarwal,Prashant Lavania,Jitendra Goyal
3Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule
Kanuj Malik,Anand Raja,Lalgudi Subramaniam Ravishankar,Kathiresan Narayanaswamy,Venkatraman Radhakrishnan,Tenali Gnana Sagar
Indian Journal of Surgical Oncology.2021;12(4)796
4Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I)
Yuvaraja B. Thyavihally,Preetham Dev,Santosh Waigankar,Abhinav Pednekar,Nevitha Athikari,Abhijit Raut,Archan Khandekar,Naresh Badlani,Ashishkumar Asari
Asian Journal of Urology.2022;9(2)157
5Dose, duration and strain of bacillus Calmette–Guerin in the treatment of nonmuscle invasive bladder cancer
Yongjun Quan,Chang Wook Jeong,Cheol Kwak,Hyeon Hoe Kim,Hyung Suk Kim,Ja Hyeon Ku
  The Journal 
  The Association 
  Site Statistics 
  Online Submission 

Submit Articles


Join us